Profile data is unavailable for this security.
About the company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. It also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The Company is present in Europe and the United States.
- Revenue in EUR (TTM)448.00k
- Net income in EUR-16.29m
- Incorporated2000
- Employees18.00
- LocationEpigenomics AGGeneststrasse 5BERLIN 10829GermanyDEU
- Phone+49 30243450
- Fax+49 3 024345555
- Websitehttps://www.epigenomics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eurocine Vaccines AB | 438.00 | -1.32m | 916.49k | 3.00 | -- | -- | -- | 2,092.35 | -0.1472 | -0.1472 | 0.00005 | -0.0018 | 0.0007 | -- | 0.002 | -- | -199.76 | -83.17 | -323.19 | -97.89 | -199,780.00 | -- | -301,180.00 | -- | -- | -- | -- | -- | -- | -- | 8.95 | -- | -- | -- |
| Amniotics AB (publ) | 0.00 | -2.70m | 933.76k | 6.00 | -- | 0.6803 | -- | -- | -0.0374 | -0.0374 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -112.25 | -101.09 | -362.71 | -149.92 | -- | -- | -- | -- | 1.12 | -16.17 | -- | -- | -- | -- | 35.75 | -- | -- | -- |
| XP Chemistries AB | 38.82k | -686.83k | 982.10k | 2.00 | -- | 0.4703 | -- | 25.30 | -0.2479 | -0.2479 | 0.0098 | 0.2552 | 0.0164 | 3.25 | 18.68 | 221,565.00 | -29.04 | -- | -30.83 | -- | -1,116.68 | -- | -1,769.29 | -- | 4.72 | -- | 0.00 | -- | -37.14 | -- | -1.55 | -- | -- | -- |
| Rapid Nutrition PLC | 1.02m | -1.24m | 1.08m | 12.00 | -- | 1,001.65 | -- | 1.06 | -0.0036 | -0.0036 | 0.0029 | 0.00006 | 2.20 | 8.35 | 18.92 | 84,638.98 | -267.55 | -- | -731.62 | -- | 22.33 | -- | -121.76 | -- | 0.8997 | -- | 0.5193 | -- | -44.01 | -- | 14.52 | -- | -- | -- |
| Diagonal Bio AB | 2.02k | -1.02m | 1.20m | 5.00 | -- | 0.1065 | -- | 597.47 | -0.1963 | -0.1963 | 0.0004 | 0.3221 | 0.0007 | -- | 2.00 | 4,600.00 | -37.35 | -- | -44.49 | -- | -41,604.35 | -- | -50,769.57 | -- | 0.5105 | -103.26 | 0.00 | -- | -88.67 | -- | 27.75 | -- | -- | -- |
| Oxurion NV | 263.00k | -18.97m | 1.23m | 20.00 | -- | -- | -- | 4.67 | -0.023 | -0.023 | 0.0002 | -0.0038 | 0.0284 | 63.60 | 0.1253 | 13,150.00 | -204.59 | -84.30 | -- | -118.70 | 39.54 | 48.90 | -7,212.55 | -2,008.99 | 0.1398 | -1.75 | -- | -- | -55.80 | -45.20 | 40.13 | -- | -65.17 | -- |
| Epigenomics AG | 448.00k | -16.29m | 1.36m | 18.00 | -- | 0.7018 | -- | 3.04 | -19.49 | -19.49 | 0.536 | 2.24 | 0.0361 | 2.73 | 3.34 | 13,176.47 | -131.18 | -65.64 | -167.31 | -83.85 | 76.56 | 89.26 | -3,636.16 | -548.19 | 1.93 | -- | 0.1572 | -- | -92.18 | -23.61 | -395.22 | -- | 44.06 | -- |
| Redwood Pharma AB | 0.00 | -1.19m | 1.44m | 1.00 | -- | 0.2424 | -- | -- | -5.87 | -5.87 | 0.00 | 3.18 | 0.00 | -- | -- | 0.00 | -106.53 | -95.03 | -121.24 | -123.04 | -- | -- | -- | -- | -- | -19.12 | 0.00 | -- | -- | -- | -8.78 | -- | -5.11 | -- |
| Aptahem AB | 2.80k | -973.53k | 1.49m | -- | -- | 0.1324 | -- | 531.10 | -0.0497 | -0.0497 | 0.0001 | 0.2266 | 0.0005 | -- | 0.0738 | -- | -16.76 | -39.26 | -19.47 | -44.19 | 4,623.59 | -- | -34,727.72 | -- | -- | -10.17 | 0.0847 | -- | -- | -- | -25.36 | -- | -- | -- |
| Theravet SA | -100.00bn | -100.00bn | 1.63m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Asarina Pharma AB (publ) | 0.00 | -1.13m | 1.65m | -- | -- | 12.05 | -- | -- | -0.5704 | -0.5704 | 0.00 | 0.069 | 0.00 | -- | -- | -- | -113.04 | -61.28 | -150.47 | -71.81 | -- | -- | -- | -- | -- | -- | 0.3902 | -- | -- | -- | 2.79 | -- | -- | -- |
| Lidds AB | 0.00 | -3.52m | 1.66m | 2.00 | -- | 0.6799 | -- | -- | -0.8316 | -0.8316 | 0.00 | 0.2037 | 0.00 | -- | -- | 0.00 | -184.54 | -46.33 | -274.93 | -51.61 | -- | -1,934.24 | -- | -3,076.68 | -- | -- | 0.00 | -- | -100.00 | -- | -9.08 | -- | -- | -- |
| AegirBio AB | 3.15k | -4.33m | 1.72m | 13.00 | -- | -- | -- | 545.49 | -2.18 | -2.18 | 0.0015 | -0.3413 | 0.0005 | -- | 0.0065 | 2,769.23 | -67.93 | -- | -82.25 | -- | 355.56 | -- | -137,155.60 | -- | 0.5183 | -43.54 | 1.40 | -- | -94.61 | -- | 83.55 | -- | -- | -- |
| Oxford Cannabinoid Tchnlgs Hldngs PLC | 0.00 | -4.98m | 1.73m | 7.00 | -- | 0.6649 | -- | -- | -0.0044 | -0.0044 | 0.00 | 0.002 | 0.00 | -- | -- | 0.00 | -82.98 | -56.41 | -104.70 | -66.13 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.16 | -- | -- | -- |
| Private Rented Sector SA | 46.83k | 6.37k | 1.75m | -- | 274.41 | -- | 79.62 | 37.33 | 0.0206 | 0.0206 | 0.1514 | -0.035 | 1.79 | -- | 2.20 | -- | 24.28 | 1,266.23 | -- | -- | 23.89 | -1,935.55 | 13.60 | 2,755.44 | -- | -- | -- | -- | -- | -- | -66.26 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Epigenomics AG's reporting currency: Euro EUR
